| 26 Aug, 02:46 pm | — | … | Natco Pharma Ltd - 524816 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 25 Aug, 12:22 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 25 Aug, 12:18 pm | — | … | Natco Pharma Limited has informed the Exchange regarding a press release dated August 25, 2026, titled "Investment in eGenesis, Inc.". | nse |
| 21 Aug, 05:27 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 21 Aug, 05:23 pm | — | … | Natco Pharma Limited has informed the Exchange regarding a press release dated August 21, 2026, titled "Conclusion of US FDA Inspection at our Visakhapatnam, Andhra Pradesh, Finished Dosage Formulations (FDF) Unit". | nse |
| 19 Aug, 09:02 am | — | … | Natco Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 19 Aug, 09:00 am | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 18 Aug, 12:41 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 18 Aug, 12:37 pm | — | … | Natco Pharma Limited has informed the Exchange about Transcript | nse |
| 16 Aug, 09:06 am | — | … | Natco Pharma Limited has informed the Exchange about Copy of Newspaper Publication for the Un-Audited Financial Results for the quarter ended June 30, 2026 and declaration of Interim Dividend for the FY ending 2026-27. | nse |
| 14 Aug, 06:59 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 14 Aug, 06:55 pm | — | … | Natco Pharma Limited has informed the Exchange about Link of Recording | nse |
| 14 Aug, 05:39 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 14 Aug, 05:37 pm | — | … | Natco Pharma Limited has informed the Exchange about Presentation | nse |
| 14 Aug, 02:20 pm | — | … | Natco Pharma Ltd - 524816 - Corporate Action-Board approves Dividend | bse |
| 14 Aug, 02:16 pm | — | … | Natco Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 20-Aug-2026. | nse |
| 14 Aug, 02:13 pm | — | … | Natco Pharma Ltd - 524816 - Board Meeting Outcome for Outcome Of Board Meeting | bse |
| 14 Aug, 02:12 pm | — | … | Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026 and declaration of Interim Dividend for the FY ending 2026-27 | nse |
| 11 Aug, 05:53 pm | — | … | Natco Pharma Ltd - 524816 - Update on board meeting | bse |
| 06 Aug, 04:50 pm | — | … | Natco Pharma Ltd - 524816 - Board Meeting Intimation for Considering Un-Audited Financial Results For The Quarter Ended 30Th June, 2026 And Declare Interim Dividend, If Any | bse |
| 18 Jul, 04:49 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 18 Jul, 04:39 pm | — | … | Natco Pharma Limited has informed the Exchange regarding a press release dated July 18, 2026, titled "NATCO received Tentative Approval for Olaparib Tablets from the United States Food and Drug Administration (U.S. FDA)". | nse |
| 14 Jul, 11:54 am | — | … | The Company has informed the Exchange regarding a press release dated July 14, 2026, titled "NATCO Pharma Limited completes acquisition of additional 13.25% stake in Adcock Ingram Holdings Proprietary Limited". | nse |
| 14 Jul, 11:49 am | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 14 Jul, 10:06 am | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | bse |
| 14 Jul, 09:56 am | — | … | Natco Pharma Limited has informed the Exchange about Action(s) taken or orders passed | nse |
| 08 Jul, 12:05 pm | — | … | Natco Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 08, 2026. | nse |
| 06 Jul, 05:47 pm | — | … | We would like to inform you that in accordance with the provisions of Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the below mentioned officials of the Company has been designated as follows w.e.f. 6th July, 2026: 1. Mr. Gnanadeva Chalapathy Gudipati has been designated as Senior Vice President - Analytical Research & Development; andMr. Madhava Rao Karicherla has been designated as Vice President Formulation Research & Devel | nse |
| 06 Jul, 05:38 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 30 Jun, 04:18 pm | — | … | Natco Pharma Limited has informed the Exchange about Mr. Nadella Malleswara Rao, Vice President - Operations, Pharma Division Kothur of the Company has superannuated today i.e., with effect from the closure of business hours on 30th June, 2026 | nse |
| 30 Jun, 04:10 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 04 Jun, 03:00 pm | — | … | Natco Pharma Limited has informed the Exchange about Transcript | nse |
| 04 Jun, 02:53 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 03 Jun, 11:15 am | — | … | Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "NATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Eribulin Mesylate Injection". | nse |
| 03 Jun, 11:14 am | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 30 May, 12:24 pm | — | … | Natco Pharma Limited has informed the Exchange about Copy of Newspaper Publication of Annual Audited Financial Results for the quarter and year ended March 31, 2026 | nse |
| 30 May, 12:19 pm | — | … | Natco Pharma Limited has informed the Exchange about Link of Recording | nse |
| 30 May, 12:18 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 29 May, 03:34 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 29 May, 03:30 pm | — | … | Natco Pharma Limited has informed the Exchange about FY26 Earnings Presentation | nse |
| 29 May, 02:28 pm | — | … | Natco Pharma Ltd - 524816 - Audited Financial Results For The Quarte And Year Ended 31St March, 2026 | bse |
| 29 May, 02:21 pm | — | … | Natco Pharma Limited has submitted to the Exchange, the Audited financial results for the quarter and year ended March 31, 2026. | nse |
| 26 May, 04:21 pm | — | … | Natco Pharma Ltd - 524816 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 18 May, 04:38 pm | — | … | Natco Pharma Ltd - 524816 - Board Meeting Intimation for Considering Audited Financial Results For The Financial Year Ended 31St March, 2026 | bse |
| 15 May, 11:47 am | — | … | Natco Pharma Ltd - 524816 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 14 May, 04:25 pm | — | … | Natco Pharma Ltd - 524816 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 14 May, 04:17 pm | — | … | Natco Pharma Limited has informed the Exchange about Action(s) initiated or orders passed | nse |
| 29 Apr, 05:30 pm | — | … | Natco Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 24 Mar, 05:30 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 24 Mar, 05:22 pm | — | … | Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement | bse |